StockWatch
·
Misc Health and Biotechnology Services
InvestmentJun 18, 2026, 08:32 AM

NewGenIvf Increases K25.ai Ownership to 10% at $100M Valuation

AI Summary

NewGenIvf Group Limited announced an additional strategic investment in PredicXion Group Limited (K25.ai), acquiring an extra 4% equity for US$4 million. This increases NewGenIvf's total ownership in K25.ai to 10%, based on an implied valuation of US$100 million. The investment completes K25.ai's US$10 million Pre-A round, and the company is now raising its Series A to support product launch and regional expansion. NewGenIvf also holds exclusive Asia-Pacific agency rights with K25.ai, deepening its strategic participation.

Key Highlights

  • NewGenIvf acquired an additional 4% equity interest in PredicXion Group Limited (K25.ai).
  • The acquisition increases NewGenIvf's aggregate ownership in K25.ai to 10%.
  • The additional 4% equity was acquired for an aggregate consideration of US$4,000,000.
  • Consideration includes US$1,900,000 payable in cash or digital assets and 1,500,000 newly issued Class A ordinary shares.
  • NewGenIvf's total investment in K25.ai now stands at US$10,000,000.
  • The transaction is based on an implied valuation of K25.ai at US$100,000,000.
  • K25.ai has closed its US$10 million Pre-A round and commenced Series A fundraising.
  • NewGenIvf holds exclusive Asia-Pacific agency rights with K25.ai.